Disease: Hypoglycemia segment

RZLT

Rezolute, Inc. - Common Stock

-2.74% -2.74% 0

+ Biopharma, Medicine, Disease: Hypoglycemia Last highlighted: #RZLT SEC report: Rezolute, Inc. Current report, items 7.01 and 9.01 SEC Filing Form 8-K filed by Rezolute, Inc. -- SEC File Number 211161853

+ My List

We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.